Abstract
POST-MARKETING SURVEILLANCE STUDY TO SUBSTANTIATE THE EFFICACY AND SAFETY FOR THE COMBINATION OF PHENYLEPHRINE AND LEVOCETIRIZINE IN THE PATIENTS OF ALLERGIC RHINITIS IN INDIAN POPULATION

Dr. Mayuresh Kiran, Lalit Pawaskar*, Pramita Waghambare and Shaheen Sheikh

ABSTRACT

Introduction: Allergic rhinitis is most commonly encountered disease in clinical practises. Allergic rhinitis is developed due to release of histamine from mast cells due to hypersensitivity to any of the allergen to which the patient has been exposed. This study was conducted to test the efficacy and safety for the treatment of allergic rhinitis patients for the fixed dose combination of Phenylephrine 10 mg and Levocetirizine 2.5 mg per tablet in Indian population. Methodology: Out of 165 enrolled, 150 trial subjects completed the study. Efficacy assessment was made by total symptom score for which the trial subjects were asked to rate the symptoms on 11-point scale ranging from 0 means no symptoms at all to 10 means the maximum tolerated symptoms. Total symptom score was further extrapolated to four-point Likert-type symptom severity scale. Reported adverse events by the recruited trial subjects during the study were used to determine the safety of the Investigational product. Results: Reduction in Total Symptom Score was from 6.98 (baseline) to 3.15 (day 3) to 0.60 (day 5). Nearly all trial subjects had >50% reduction in total symptom score at all visits and most of the trial subjects had complete relief from the symptom of allergic rhinitis. Also, no serious or un-expected adverse event was reported during the study. Conclusion: Combination of Phenylephrine and Levocetirizine was found efficacious as well as safe for the treatment of allergic rhinitis.

Keywords: Phenylephrine, Levocetirizine, Allergic Rhinitis.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • EJBPS: JULY ISSUE PUBLISHED

    JULY 2021 Issue has been successfully launched on 1 July 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT